TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9642894

Group type: EXPERIMENTAL
Intervention: Both sorts of information (outcome information and self‐efficacy‐enhancing information)
Number of subjects: 1540

Group type: EXPERIMENTAL
Intervention: Self‐efficacy‐enhancing information only
Number of subjects: 1540

Group type: COMPARATOR
Intervention: No information (control group)
Number of subjects: 1540

Group type: EXPERIMENTAL
Intervention: Matched treatment
Number of subjects: 1540

Group type: EXPERIMENTAL
Intervention: Mismatched treatment
Number of subjects: 1540
Study: 8076488

Group type: EXPERIMENTAL
Intervention: Primary closure with drainage
Number of subjects: 45

Group type: COMPARATOR
Intervention: Packing
Number of subjects: 45
Study: 2518871

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg nocte
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 780103

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CARB)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Diphenylhydantoin (DPH)
Number of subjects: 38
Study: 31218531

Group type: EXPERIMENTAL
Intervention: Medication + CT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Medication + non-active training
Number of subjects: 20
Study: 31003673

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with exercise therapy and conventional rehabilitation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rehabilitation training alone
Number of subjects: 0
Study: 28493030

Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (HIIT) (>90% of maximal heart rate, 85% VO2max)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT) (70% of maximal heart rate, 60% VO2max)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (REST)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (HIIT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 19
Study: 25304294

Group type: EXPERIMENTAL
Intervention: Mediterranean-type dietary pattern (MDP)
Number of subjects: 7216

Group type: COMPARATOR
Intervention: Western dietary pattern (WDP)
Number of subjects: 7216
Study: 23989947

Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.4 mg m(‐2) combined with DTIC 800 mg m(‐2) q4wk (n = 38)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Single-agent plitidepsin 3.2 mg m(‐2) (n = 20)
Number of subjects: 58
Study: 22095049

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Etanercept, interferon-γ, bosentan, ambrisentan, imatinib, sildenafil
Number of subjects: 1100
Study: 18331462

Group type: EXPERIMENTAL
Intervention: Asimadoline 0.5 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Asimadoline 1.0 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16709209

Group type: EXPERIMENTAL
Intervention: 12-week scan group
Number of subjects: 39572

Group type: COMPARATOR
Intervention: 18-week scan group
Number of subjects: 39572
Study: 15656399

Group type: EXPERIMENTAL
Intervention: Dipyridamole (curantyl, 100 mg a week)
Number of subjects: 2333

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2333
Study: 11720042

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical tretinoin
Number of subjects: 40
Study: 9144756

Group type: EXPERIMENTAL
Intervention: Physician message
Number of subjects: 2233

Group type: EXPERIMENTAL
Intervention: Physician message and BSE class
Number of subjects: 2233

Group type: EXPERIMENTAL
Intervention: Physician message, BSE class, and reinforcement (phone and postcard)
Number of subjects: 2233
Study: 8181800

Group type: EXPERIMENTAL
Intervention: Imidapril 5 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Imidapril 20 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Imidapril (5 mg and 20 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3371098

Group type: EXPERIMENTAL
Intervention: Single sclerotherapy treatment with tetracycline at a dose of 20 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Two sclerotherapy treatments with tetracycline
Number of subjects: 50
Study: 30343531

Group type: EXPERIMENTAL
Intervention: IXEQ2W (80 mg subcutaneous ixekizumab every 2 weeks)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: IXEQ4W (80 mg subcutaneous ixekizumab every 4 weeks)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: IXEQ2W and IXEQ4W
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: IXEQ2W
Number of subjects: 316
Study: 29095374

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy-Case Management (DBT-CM)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Health Promotion (HP)
Number of subjects: 130
Study: 25460339

Group type: EXPERIMENTAL
Intervention: Long-term mild hypothermia (34-35 °C) for 5 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Normothermia (36-37 °C)
Number of subjects: 300
Study: 22717286

Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle education programme (6 sessions over 7 ± 1 months)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 198
Study: 22026392

Group type: EXPERIMENTAL
Intervention: Oral atorvastatin 40 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18773915

Group type: EXPERIMENTAL
Intervention: Tailored Internet arm (n=81; instantaneous web‐based tailored feedback)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Standard Internet arm (n=82; websites currently available to the public)
Number of subjects: 163
Study: 16541933

Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation programme (4 rehabilitation sessions over 10 days in 18 months)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 76
Study: 12788572

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus iron supplementation
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Iron supplementation only
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 10952952

Group type: COMPARATOR
Intervention: Control diet (low in fruits, vegetables, and dairy products)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Combination diet (rich in fruits, vegetables, and low-fat dairy products, reduced in saturated and total fat)
Number of subjects: 118
Study: 8620234

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium, 20 mg four times a day for 8 weeks and 20 mg three times a day for 8 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Budesonide, 500 micrograms twice a day for 8 weeks and 250 micrograms twice a day for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 100
Study: 1468164

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg three times a day for three days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 18
Study: 3882677

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31340957

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination in the natural cycle
Number of subjects: 416

Group type: COMPARATOR
Intervention: Intracervical insemination in the natural cycle
Number of subjects: 416
Study: 29240594

Group type: EXPERIMENTAL
Intervention: Multilayer skin interface support system (Bedcare) used on top of a viscoelastic foam mattress (Formafoam)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Viscoelastic foam mattress (Formafoam) covered with a cotton sheet
Number of subjects: 206
Study: 27390378

Group type: EXPERIMENTAL
Intervention: Secure E-mails
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Contacting clinic directors
Number of subjects: 733

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 733
Study: 24930596

Group type: EXPERIMENTAL
Intervention: Text messaging (TXT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Paper-and-pencil (PNP)
Number of subjects: 44
Study: 23294774

Group type: EXPERIMENTAL
Intervention: Adaptive, dose-finding, seamless phase 2/3 trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug supply management for nine treatment arms
Number of subjects: 0
Study: 19830496

Group type: EXPERIMENTAL
Intervention: Preoperative quality of life (QoL) measurements
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Postoperative quality of life (QoL) measurements
Number of subjects: 199
Study: 17010115

Group type: EXPERIMENTAL
Intervention: Active, multifaceted educational intervention using the WHO Reproductive Health Library (RHL) over a period of 6 months.
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1000
Study: 16144950

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13
Study: 12110062

Group type: EXPERIMENTAL
Intervention: Study of Osteoporotic Fractures guidelines
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: World Health Organization (WHO) recommendations
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: National Osteoporosis Foundation guidelines
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: WHO guidelines based on low BMD alone
Number of subjects: 428
Study: 9890620

Group type: EXPERIMENTAL
Intervention: Malignant group (treated with antineoplastic agents)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Nonmalignant group (received transfusions for nonmalignant diseases)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: HCV group
Number of subjects: 162

Group type: COMPARATOR
Intervention: HBV and non-A-C hepatitis groups
Number of subjects: 162
Study: 7745044

Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination (IUI)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Timed intercourse with cyclic, low-dose prednisolone (20 mg)
Number of subjects: 46
Study: 2405533

Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed schedule (neutrons + photons)
Number of subjects: 0
Study: 6775301

Group type: EXPERIMENTAL
Intervention: Sustained-release nitroglycerin capsules
Number of subjects: 25
Study: 30039991

Group type: EXPERIMENTAL
Intervention: Low-Volume, High-Intensity Training (HIT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-Intensity, High-Volume Training (HVT)
Number of subjects: 16
Study: 30115425

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (<120 mm Hg)
Number of subjects: 6875

Group type: COMPARATOR
Intervention: Standard blood pressure control (130-139 mm Hg)
Number of subjects: 6875
Study: 27329373

Group type: EXPERIMENTAL
Intervention: Motivational-interviewing intervention
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Counseling sessions
Number of subjects: 52
Study: 24263324

Group type: EXPERIMENTAL
Intervention: BMI + B
Number of subjects: 596

Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 596

Group type: COMPARATOR
Intervention: Brief motivational intervention (BMI)
Number of subjects: 596
Study: 22873530

Group type: EXPERIMENTAL
Intervention: 5 mg tofacitinib twice daily
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: 10 mg tofacitinib twice daily
Number of subjects: 611

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study: 19287182

Group type: EXPERIMENTAL
Intervention: Pulsatile cardiopulmonary bypass (CPB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonpulsatile cardiopulmonary bypass (CPB)
Number of subjects: 50
Study: 17786056

Group type: EXPERIMENTAL
Intervention: Angiotensin II Receptor Blockers (ARBs)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Angiotensin-Converting Enzyme (ACE) inhibitors
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCBs)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: ARBs
Number of subjects: 301
Study: 15027165

Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total parenteral nutrition
Number of subjects: 0
Study: 12109357

Group type: EXPERIMENTAL
Intervention: Selenium treatment
Number of subjects: 0
Study: 10077049

Group type: EXPERIMENTAL
Intervention: Intermittent pedicular clamping (IPC)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Continuous pedicular clamping (CPC)
Number of subjects: 86
Study: 7586390

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 558
Study: 2322085

Group type: EXPERIMENTAL
Intervention: Morning light exposure
Number of subjects: 13

Group type: COMPARATOR
Intervention: Evening light exposure
Number of subjects: 13
Study: 85177

Group type: EXPERIMENTAL
Intervention: Patient-recorded peak expiratory-flow rate (P.E.F.R.)
Number of subjects: 50
Study: 30578164

Group type: EXPERIMENTAL
Intervention: Diabetes education plus diabetes health coaching
Number of subjects: 365

Group type: COMPARATOR
Intervention: Usual diabetes education
Number of subjects: 365
Study: 28894283

Group type: EXPERIMENTAL
Intervention: JinqiJiangtang tablets (JQJT tablets)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 25643028

Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = .08 g%) in lab context
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo in lab context
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = .08 g%) in simulated bar context
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo in simulated bar context
Number of subjects: 157
Study: 23499270

Group type: EXPERIMENTAL
Intervention: XIENCE V
Number of subjects: 3687

Group type: COMPARATOR
Intervention: Taxus Express(2)
Number of subjects: 3687
Study: 21115863

Group type: COMPARATOR
Intervention: IV amifostine (200 mg/m(2) daily for 3 minutes, 15 to 30 minutes before irradiation)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: SC amifostine (500 mg; two sites; 20 to 60 minutes before irradiation)
Number of subjects: 291
Study: 19263186

Group type: EXPERIMENTAL
Intervention: 30 mg of oral L‐amphetamine sulfate for 29 days
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 16765378

Group type: EXPERIMENTAL
Intervention: Cognitive training regimen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 26
Study: 10937952

Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Losartan 12.5 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 18
Study: 8904626

Group type: EXPERIMENTAL
Intervention: 500 mg tablet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 850 mg tablet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 850 mg solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 850 mg tablet with food
Number of subjects: 24

Group type: COMPARATOR
Intervention: 850 mg tablet fasting
Number of subjects: 24
Study: 1365471

Group type: EXPERIMENTAL
Intervention: 2.5% percutaneous niflumic acid gel applied three times daily for 7 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo gel applied three times daily for 7 days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Niflumic acid gel
Number of subjects: 59
Study: 6346781

Group type: EXPERIMENTAL
Intervention: Ritodrine treatment
Number of subjects: 147
Study: 31797232

Group type: EXPERIMENTAL
Intervention: Online sampling and anonymous interviewing
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Randomized experiment
Number of subjects: 15000
Study: 29979327

Group type: EXPERIMENTAL
Intervention: Modified minimally invasive single‐incision technique (MSIT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional trap‐door incision technique (TDIT)
Number of subjects: 40
Study: 27628506

Group type: EXPERIMENTAL
Intervention: Immediate tones training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed tones training
Number of subjects: 50
Study: 25306742

Group type: EXPERIMENTAL
Intervention: Itopride (Ganaton) oral tablets 50 mg, 3 times daily for 8 weeks
Number of subjects: 96
Study: 23200288

Group type: EXPERIMENTAL
Intervention: Emotion Regulation Training (ERT) + Treatment as Usual (TAU)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 109
Study: 20718542

Group type: EXPERIMENTAL
Intervention: Stimuli experienced by more similar others (Study 1, 2, and 3)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Stimuli experienced by less similar others (Study 1, 2, and 3)
Number of subjects: 3
Study: 18252070

Group type: EXPERIMENTAL
Intervention: Bio yogurt (150 ml of live strawberry-flavoured yogurt for 12 days)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Commercial yogurt
Number of subjects: 369

Group type: COMPARATOR
Intervention: No yogurt
Number of subjects: 369
Study: 16295218

Group type: EXPERIMENTAL
Intervention: Self-help treatment
Number of subjects: 192

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 192
Study: 12450697

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10803488

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 44
Study: 8564429

Group type: EXPERIMENTAL
Intervention: NaCl adaptation
Number of subjects: 0

Group type: COMPARATOR
Intervention: KCl
Number of subjects: 0
Study: 31709879

Group type: EXPERIMENTAL
Intervention: Exercise challenge in non-EIB asthmatics (n = 31)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Exercise challenge in EIB asthmatics (n = 25)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Stable asthmatic children
Number of subjects: 91

Group type: COMPARATOR
Intervention: Children with asthma exacerbation
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Correlation with ACT score
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Correlation with baseline FEV1 level
Number of subjects: 91
Study: 27918682

Group type: EXPERIMENTAL
Intervention: Interrepetition rest configuration (32 maximum intended velocity repetitions, 10RM load, 17.4 s of rest between each repetition)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Traditional configuration (4 sets of 8 repetitions at maximum intended velocity, 10RM load, 3‐min pause between sets)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both training protocols
Number of subjects: 13
Study: 25995055

Group type: EXPERIMENTAL
Intervention: NEI-VFQ-25 composite score
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Multiple linear regression model
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Overall health-related quality of life (QOL)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vision-specific QOL
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: IIH treatment
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: QOL assessment
Number of subjects: 165
Study: 23416014

Group type: EXPERIMENTAL
Intervention: Meteorological events (temperature drops, wind speed increases, relative humidity increases)
Number of subjects: 9406

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 9406
Study: 21707766

Group type: EXPERIMENTAL
Intervention: Silodosin (8 mg/daily for a maximum of 8 weeks)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (drinking 2 L of water daily)
Number of subjects: 187
Study: 19772449

Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 385

Group type: COMPARATOR
Intervention: SC insulin (regular human insulin or insulin lispro)
Number of subjects: 385
Study: 17326352

Group type: EXPERIMENTAL
Intervention: epi-LASIK
Number of subjects: 57

Group type: COMPARATOR
Intervention: LASEK
Number of subjects: 57

Group type: COMPARATOR
Intervention: PRK
Number of subjects: 57
Study: 15161789

Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg/day
Number of subjects: 93
Study: 11139307

Group type: EXPERIMENTAL
Intervention: Amifostine 740 mg/m² immediately prior to chemotherapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Amifostine with chemotherapy
Number of subjects: 84
Study: 9722203

Group type: EXPERIMENTAL
Intervention: Reinforced regimen (6 MU daily for 12 days, 6 MU thrice a week for 22 weeks, 3 MU thrice a week for 24 weeks)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Standard regimen (3 MU thrice a week for 24 weeks)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Reinforced regimen
Number of subjects: 244
Study: 7989961

Group type: EXPERIMENTAL
Intervention: Subgingival applications of HPMC membranes containing 20% chlorhexidine and 40% doxycycline, applied twice a week for 6 weeks.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Subgingival scaling and root planing (control group), performed at 0, 1, 3, and 6 weeks.
Number of subjects: 11